Cipla Limited (NSEI:CIPLA) agreed to acquire nutrition products portfolio from Wanbury Limited (BSE:524212) for INR 886 million on October 10, 2019. The portfolio consist of 4 brands - CPink, CDense, Productiv and Folinine with a sales value of INR 600 million in India. The transaction is expected to close on February 10, 2020. Khaitan & Co. acted as legal advisor for Wanbury Limited.

Cipla Limited (NSEI:CIPLA) completed the acquisition of nutrition products portfolio from Wanbury Limited (BSE:524212) on February 7, 2020.